Yamaha Motor India has announced price reductions for two of its motorcycles, the R3 and MT-03, following the government’s recent GST reforms. The move comes as the GST on motorcycles with engine ...

The YZF-R3 is priced at Rs 3.39 lakh, while the MT-03 now costs Rs 3.30 lakh (ex-showroom). The prices of the Yamaha YZF-R3 and MT-03 have reduced significantly following the recent GST rate cut. Both ...

Walk into a Yamaha showroom today and you will see new price cards on its twin-cylinder pair. The R3 now lists at ₹3.39 lakh ex-showroom, while the MT-03 reads ₹3.29 lakh. Just two weeks ago both ...

Yamaha Motor India has announced significant price reductions for its popular R3 and MT-03 motorcycles, making them more accessible. Following recent government GST reforms on bikes under 350cc, both ...

Yamaha India has announced the revised prices of two of its middle-weight motorcycles, R3 and MT-03, post GST reforms. The reduction in the GST rates for motorcycles with a capacity lower than 350 cc ...

Your browser does not support the audio element. Every two-wheeler brand in India has been revising the prices of its products following the recent Goods and Services ...

Yamaha Motor India recently revised the prices of its smaller motorcycles sold in the Indian market after the announcement of revised GST slabs. The max price cut announced by the Japanese automaker ...

Recently, Yamaha Motor India announced the new prices of its portfolio in response to the revised GST 2.0 tax slabs introduced by the Indian Government. The maximum price cut was enjoyed by its ...

Yamaha’s 2026 off-road ATV lineup includes both the Grizzly and Kodiak models. (Photos: Yamaha Motors) The 2026 sport ATV lineup includes the YFZ450R, a premium choice for ATV racers, and the Raptor ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The eye drop achieved noninferiority in lowering IOP vs.

Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that once daily dosing of NCX 470 0.1%, a novel nitric oxide (NO)-donating bimatoprost ...